Blood advances : Impact Factor & More
eISSN: 2473-9537pISSN: 2473-9529
Share this on:
Key Metrics
CiteScore 
9.6
Eigenfactor
0.01 - 0.05
H-Index
69
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SJR
Q1Hematology
SNIP
1.95
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Blood advances
Blood advances Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Blood advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Blood advances
Impact of oral iron dosing regimens on iron biomarkers during pregnancy: insights from the PANDA trial.
- 14 Jul 2026
- Blood advances
Three generations, one target: BTK inhibitors in lymphoma.
- 14 Jul 2026
- Blood advances
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells.
- 14 Jul 2026
- Blood advances
Improving control arms in 2026 US myeloma trials.
- 14 Jul 2026
- Blood advances
Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.
- 14 Jul 2026
- Blood advances
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.
- 14 Jul 2026
- Blood advances
Impact of oral iron dosing regimens on iron biomarkers during pregnancy: insights from the PANDA trial.
- 14 Jul 2026
- Blood advances
Three generations, one target: BTK inhibitors in lymphoma.
- 14 Jul 2026
- Blood advances
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells.
- 14 Jul 2026
- Blood advances
Improving control arms in 2026 US myeloma trials.
- 14 Jul 2026
- Blood advances
Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.
- 14 Jul 2026
- Blood advances
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.
- 14 Jul 2026
- Blood advances
FAQs on Blood advances
How long has Blood advances been actively publishing? 
What is the publishing frequency of Blood advances?
How many articles did Blood advances publish last year?
What is the eISSN & pISSN for Blood advances?
What is Citescore for Blood advances?
What is the H Index for Blood advances ?
What is SNIP score for Blood advances?
What is the SJR for Blood advances?
Who is the publisher of Blood advances?
